Ganaplacide

DRUG3 trials

Sponsors

Novartis Pharmaceuticals

Conditions

Malaria

Phase 1

Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Itraconazole

CompletedNCT05084651

Novartis PharmaceuticalsMalaria

Start: 2021-11-18End: 2022-05-14Updated: 2022-10-28

Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir

CompletedNCT05236530

Novartis PharmaceuticalsMalaria

Start: 2022-03-09End: 2022-10-17Updated: 2022-11-04

Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Efavirenz

CompletedNCT05330273

Novartis PharmaceuticalsMalaria

Start: 2022-04-28End: 2022-11-22Updated: 2023-01-12